VEGFD and gastric cancer: The results of the angiogenesis arrays revealed that the OmAd-CM-treated cells showed higher gene expressions of VEGFA, IFNB, VEGFD and ANGPTL4 compared with the control cells, and revealed consistent results in both of the GC cell lines (Fig. 2k).